Long term follow-up of a tobacco prevention and cessation program in cystic fibrosis patients
DOI:
https://doi.org/10.20882/adicciones.778Keywords:
Environmental tobacco smoke, cystic fibrosis, smoking prevention and cessationAbstract
This study evaluates the impact over time of a telephone-based intervention in tobacco cessation and prevention targeting patients with cystic fibrosis (CF) in the Mediterranean region of Murcia, Spain. We conducted an experimental prospective study with a cohort of CF patients using an integrative smoking cessation programme, between 2008 and 2013. The target population included family members and patients from the Regional CF unit. The study included an initial tobacco exposure questionnaire, measurement of lung function, urinary cotinine levels, anthropomorphic measures and the administered intervention at specific time intervals. Of the 88 patients tracked through follow-up, active smoking rates were reduced from 10.23% to 4.55% (p = 0.06). Environmental tobacco exposure was reduced in non-smoker patients from 62.03% to 36.90% (p < 0.01) during the five year follow-up. Significant reductions in the gradient of household tobacco smoke exposure were also observed with a decrease of 12.60%, from 31.65% (n = 25/79) to 19.05% (n = 16/84) in 2013 (p = <0.01). Cotinine was significantly correlated with both active and passive exposure (p<0.01) with a significant reduction of cotinine levels from 63.13 (28.58-97.69) to 20.56 (0.86-40.27) ng/ml (p<0.01). The intervention to significantly increase the likelihood of family quitting (smoke-free home) was 1.26 (1.05-1.54). Telephone based interventions for tobacco cessation and prevention is a useful tool when applied over time. Trained intervention professionals in this area are needed in the environmental health approach for the treatment of CF.References
Beers, M. H. y Berkow, R. (1999). Cystic Fibrosis. In: R. S. Porter (Ed.), Merck Manual: Diagnosis & Therapy. 17th ed. (pp. 2366-2371). Whitehouse Station, NJ: Merck & Co Inc.
Butz, A.M. y Rosenstein, B. J. (1999). Passive smoking among children with chronic respiratory disease. Journal of Asthma, 29, 265-272.
Carreras Castellet, J. M., Maldonado Aróstegui, B., Quesada Laborda, M., Sánchez Sánchez, B., Nerín de la Puerta, I. y Sánchez Agudo, L. (2012). Tratamiento por teléfono del tabaquismo. Factores predictivos de éxito. Medicina Clínica, 138, 242-5.
Chen, Y. F., Madan, J., Welton, N., Yahaya, I., Aveyard, P., Bauld, L.,… Munafò, M. R. (2012). Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technology Assessment, 16, 1-205.
Cook, D. G., Strachan, D. P. y Carey, I. M. (1998). Parental smoking and spirometric indices in children. Thorax, 53, 884-893.
Eidt-Koch, D., Wagner, T. O., Mittendorf, T. y Graf von der Schulenburg, J. M. (2010). Outpatient medication costs of patients with cystic fibrosis in Germany. Applied Health Economics and Health Policy, 8, 111-118.
Farrell, P. M. (2008). The prevalence of cystic fibrosis in the European Union. Journal of Cystic Fibrosis, 7, 450-453.
Ferris, B. G. (1978). Epidemiology standardization project (American Thoracic Society). American Review of Respiratory Diseases, 118, 1-120.
Kopp, B. T., Sarzynski, L., Khalfoun, S., Hayes, D. Jr., Thompson, R., Nicholson, L.,… Groner, J. (2015). Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis. Pediatric Pulmonology, 50, 25-34. doi: 10.1002/ppul.23016.
Lancaster, T. y Stead, L. F. (2005). Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, 18, CD001292.
Ley 42/2010. Medidas sanitarias frente al tabaquismo y reguladora de la venta, el suministro, el consumo y la publicidad de los productos del tabaco. Boletín Oficial del Estado, Madrid, 30 de diciembre de 2010. Recuperado de http://www.boe.es/boe/dias/2010/12/31/pdfs/BOE-A-2010-20138.pdf. Consultado el 14 de junio de 2014.
Mc Ewan, F. A., Hodson, M. E. y Simmonds, N. J. (2012). The prevalence of “risky behaviour” in adults with cystic fibrosis. Journal of Cystic Fibrosis, 11, 56-58.
Ministerio de Sanidad y Consumo. (2007). Encuesta Nacional de Salud de España 2006: estilos de vida (lifestyles). Madrid: Ministerio de Sanidad y Consumo. Recuperado de http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/encuesta2006.htm. Consultado el 14 de junio de 2014.
Murcia Salud. (2006). Consumo de tabaco en Murcia y España [on line]. Recuperado de http://www.murciasalud.es/pagina.php?id=87967. Consultado el 19 de junio de 2014.
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B.,… Gakidou, E. (2014). Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012. JAMA, 311, 183-192.
Ortega-García, J. A., Ferrís Tortajada, J. y Sánchez-Solís, M. (2008). Ambientes saludables para la infancia y adolescencia [Healthy environments for children and adolescents]. In: M. T. Muñoz-Calvo, M. I. Hidalgo-Vicario, J. Clemente-Pollán (Eds.), Pediatría extrahospitalaria. 4th ed. (pp. 235-244). Madrid: Ergón.
Ortega-García, J. A., Gutierrez-Churango, J. E., Sánchez-Sauco, M. F., Martínez-Aroca, M., Delgado-Marín, J. L., Sánchez-Solis, M.,… Martínez-Lage, J. F. (2012b). Head circumference at birth and exposure to tobacco, alcohol and illegal drugs during early pregnancy. Child’s Nervous System, 28, 433-439.
Ortega-García, J. A., López-Fernández, M. T., Llano, R., Pastor-Vivero, M. D., Mondéjar-López, P., Sánchez-Sauco, M. F. y Sánchez-Solís, M. (2012a). Smoking prevention and cessation programme in cystic fibrosis: integrating an environmental health approach. Journal of Cystic Fibrosis, 11, 34-39.
Raju, S. V., Jackson, P. L., Courville, C. A., McNicholas, C. M., Sloane, P.A., Sabbatini, G.,… Rowe, S. M. (2013). Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. American Journal of Respiratory and Critical Care Medicine, 188, 1321-1330.
Ramon, J. M., Nerin, I., Comino, A., Pinet, C., Abella, F., Carreras, J. M.,… Aumatell, C. (2013). A multicentre randomized trial of combined individual and telephone counselling for smoking cessation. Preventive Medicine, 57, 183-8.
Redmond, L. A., Adsit, R., Kobinsky, K. H., Theobald, W. y Fiore, M. C. (2010). A decade of experience promoting the clinical treatment of tobacco dependence in Wisconsin. Wisconsin Medical Journal, 109, 71-78.
Rice, V. H., Hartmann-Boyce, J. y Stead, L. F. (2013). Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews, 8, CD001188.
Smyth, A., O’Hea, U., Williams, G., Smyth, R. y Heaf, D. (1994). Passive smoking and impaired lung function in cystic fibrosis. Archives of Disease in Childhood, 71, 353-354.
Stanton, A. y Grimshaw, G. (2013). Tobacco cessation interventions for young people. Cochrane Database of Systematic Reviews, 8, CD003289.
Stead, L. F. y Lancaster, T. (2012). Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database of Systematic Reviews, 12, CD009670.
Stead, L. F., Hartmann-Boyce, J., Perera, R. y Lancaster T. (2013). Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews, 8, CD002850.
Stern, R. C., Byard, P. J., Tomashefski, J. F. Jr. y Doershuk, C. F. (1987). Recreational use of psychoactive drugs by patients with cystic fibrosis. Journal of Pediatrics, 111, 293-299.
Tyc, V.L. y Throckmorton-Belzer, L. (2006). Smoking rates and the state of smoking interventions for children and adolescents with chronic illness. Pediatrics, 118, 471-487.
Verma, A., Clough, D., McKenna, D., Dodd, M. y Webb, A. K. (2001). Smoking and Cystic Fibrosis. Journal of the Royal Society of Medicine, 94, 29-34.
Winickoff, J. P., Hillis, V. J., Palfrey, J. S., Perrin, J. M. y Rigotti, N. A. (2003). A smoking cessation intervention for parents of children who are hospitalized for respiratory illness: The Stop Tobacco Outreach Program. Pediatrics, 111, 140-145.
